• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Medicines360

Anonymous board for Medicines360
Replies
0
Views
389
anonymous
Replies
0
Views
212
anonymous
Replies
0
Views
268
anonymous
Replies
0
Views
464
anonymous
Replies
2
Views
2K
anonymous
Replies
1
Views
2K
anonymous
Replies
0
Views
5K
anonymous